Gameto

Gameto

Private
Austin, TexasHealthcare & Life Scienceshttps://www.gametogen.com

Last Round

Series C

Aug 12, 2025

Est. Valuation

$250M

Total Funding Raised

$117M

Momentum Score

75 /100

Company Overview

Gameto is a biotechnology company focused on developing innovative solutions for diseases affecting the female reproductive system through engineered ovarian cell lines that replicate natural cell functions and hormone responses to address accelerated ovarian aging.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

in-vitro maturationIVMfertility treatmentwomen's healthfemtechcell engineeringIVFegg freezingassisted reproductive technologyARTfertility clinicsinduced pluripotent stem cellsiPSCscell-based therapeuticorganoid platformmenopause treatmentovarian agingdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gameto Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Gameto Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CAug 12, 2025
GrantOct 23, 2024
Series BMay 29, 2024
Series A ExtensionSep 14, 2022
Series AJan 10, 2022
Seed
Mar 1, 2020

Key People

Founding team and executive leadership

Dina Radenkovic Turner

Co-founder CEO

Founding Team

Gameto Investors

Notable investors and investment history

InvestorRounds
RA Capital ManagementSeries C, Series B
Future VenturesSeries B, Series C, Series A Extension, Series A
SALT FundSeed
Khosla VenturesSeries C
Pontiva Healthcare PartnersSeries C
GaingelsSeries A Extension
SALT Fund ISeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 43% MoM, reaching 7.8K.

  • Mar 1, 2026

    Selected for ARPA-H Sprint for Women’s Health support.

Gameto Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Gameto Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gameto's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Employee Range58
Year Founded2020
Last FundingAug 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.